SCYNEXIS to Provide a Corporate Update and Report Third Quarter 2023 Financial Results on November 10
JERSEY CITY, N.J., Nov. 03, 2023 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced it will host a conference call and live webcast at 8:30…